These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 19120719)

  • 1. Early antihypertensive efficacy of olmesartan medoxomil.
    Saito I; Kushiro T; Ishikawa M; Matsushita Y; Sagawa K; Hiramatsu K; Komiya M
    J Clin Hypertens (Greenwich); 2008 Dec; 10(12):930-5. PubMed ID: 19120719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and tolerability of olmesartan medoxomil in patients with mild to moderate essential hypertension: the OLMEBEST Study.
    Barrios V; Boccanelli A; Ewald S; Girerd X; Heagerty A; Krzesinski JM; Lins R; Rodicio J; Stefenelli T; Woittiez A; Böhm M
    Clin Drug Investig; 2007; 27(8):545-58. PubMed ID: 17638395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive efficacy of olmesartan medoxomil and ramipril in elderly patients with mild to moderate hypertension grouped according to renal function status : a retrospective analysis.
    Malacco E; Omboni S; Mallion JM; Volpe M;
    High Blood Press Cardiovasc Prev; 2012 Dec; 19(4):213-22. PubMed ID: 23430666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term efficacy of olmesartan medoxomil in Chinese hypertensive patients as assessed by clinic, ambulatory and home blood pressure measurements.
    Wang JG; Sun NL; Ke YN; Zhang BH; Ikegami N; Zhu JR
    Clin Drug Investig; 2012 Nov; 32(11):729-34. PubMed ID: 23018282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A titrate-to-goal study of switching patients uncontrolled on antihypertensive monotherapy to fixed-dose combinations of amlodipine and olmesartan medoxomil ± hydrochlorothiazide.
    Weir MR; Hsueh WA; Nesbitt SD; Littlejohn TJ; Graff A; Shojaee A; Waverczak WF; Qian C; Jones CJ; Neutel JM
    J Clin Hypertens (Greenwich); 2011 Jun; 13(6):404-12. PubMed ID: 21649839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of olmesartan medoxomil 40 mg/hydrochlorothiazide 12.5 mg combination therapy versus olmesartan medoxomil 40 mg monotherapy in patients with moderate to severe hypertension: a randomized, double-blind, parallel-group, multicentre, multinational, phase III study.
    Fogari R; Taddei S; Holm-Bentzen M; Baszak J; Melani L; Schumacher K
    Clin Drug Investig; 2010; 30(9):581-97. PubMed ID: 20593911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerability of olmesartan medoxomil combined with amlodipine in patients with moderate to severe hypertension after amlodipine monotherapy: a randomized, double-blind, parallel-group, multicentre study.
    Volpe M; Brommer P; Haag U; Miele C
    Clin Drug Investig; 2009; 29(1):11-25. PubMed ID: 19067471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Olmesartan medoxomil evaluated for safety and efficacy in Indian patients with essential hypertension: a real world observational postmarketing surveillance.
    Rana R; Singh A
    J Assoc Physicians India; 2010 Feb; 58():77-83. PubMed ID: 20653147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of an olmesartan medoxomil-based treatment regimen in hypertensive patients.
    Oparil S; Chrysant SG; Kereiakes D; Xu J; Chavanu KJ; Waverczak W; Dubiel R
    J Clin Hypertens (Greenwich); 2008 Dec; 10(12):911-21. PubMed ID: 19120717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triple therapy with olmesartan medoxomil, amlodipine besylate, and hydrochlorothiazide in adult patients with hypertension: The TRINITY multicenter, randomized, double-blind, 12-week, parallel-group study.
    Oparil S; Melino M; Lee J; Fernandez V; Heyrman R
    Clin Ther; 2010 Jul; 32(7):1252-69. PubMed ID: 20678674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of long-term treatment with the combination of amlodipine besylate and olmesartan medoxomil in patients with hypertension.
    Chrysant SG; Oparil S; Melino M; Karki S; Lee J; Heyrman R
    J Clin Hypertens (Greenwich); 2009 Sep; 11(9):475-82. PubMed ID: 19751459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood pressure goal achievement with olmesartan medoxomil-based treatment: additional analysis of the OLMEBEST study.
    Barrios V; Escobar C; Calderon A; Böhm M
    Vasc Health Risk Manag; 2009; 5():723-9. PubMed ID: 19756164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Olmesartan medoxomil plus amlodipine increases efficacy in patients with moderate-to-severe hypertension after monotherapy: a randomized, double-blind, parallel-group, multicentre study.
    Barrios V; Brommer P; Haag U; Calderón A; Escobar C
    Clin Drug Investig; 2009; 29(7):427-439. PubMed ID: 19499960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of an amlodipine/olmesartan treatment algorithm in patients with or without type 2 diabetes and hypertension (a secondary analysis of the BP-CRUSH study).
    Nesbitt SD; Shojaee A; Maa JF; Weir MR
    J Hum Hypertens; 2013 Jul; 27(7):445-52. PubMed ID: 23254596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between the frequency of blood pressure self-measurement and blood pressure reduction with antihypertensive therapy : results of the OLMETEL (OLMEsartan TELemonitoring blood pressure) study.
    Ewald S; vor dem Esche J; Uen S; Neikes F; Vetter H; Mengden T
    Clin Drug Investig; 2006; 26(8):439-46. PubMed ID: 17163276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Olmesartan medoxomil-based antihypertensive therapy evaluated by ambulatory blood pressure monitoring: efficacy in high-risk patient subgroups.
    Chrysant SG; Germino FW; Neutel JM
    Am J Cardiovasc Drugs; 2012 Dec; 12(6):375-89. PubMed ID: 23116225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of olmesartan medoxomil and hydrochlorothiazide fixed-dose combination therapy in patients aged 65 years and older with stage 1 and 2 hypertension or isolated systolic hypertension.
    Germino FW; Neutel JM; Dubiel R; Maa JF; Chavanu KJ
    Am J Cardiovasc Drugs; 2012 Oct; 12(5):325-33. PubMed ID: 22920048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of amlodipine and olmesartan medoxomil in patients with hypertension: the AZOR Trial Evaluating Blood Pressure Reductions and Control (AZTEC) study.
    Punzi H; Neutel JM; Kereiakes DJ; Shojaee A; Waverczak WF; Dubiel R; Maa JF
    Ther Adv Cardiovasc Dis; 2010 Aug; 4(4):209-21. PubMed ID: 20519261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The combination of olmesartan medoxomil and amlodipine besylate in controlling high blood pressure: COACH, a randomized, double-blind, placebo-controlled, 8-week factorial efficacy and safety study.
    Chrysant SG; Melino M; Karki S; Lee J; Heyrman R
    Clin Ther; 2008 Apr; 30(4):587-604. PubMed ID: 18498909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systolic blood pressure reduction with olmesartan medoxomil versus nitrendipine in elderly patients with isolated systolic hypertension.
    Mallion JM; Heagerty A; Laeis P
    J Hypertens; 2007 Oct; 25(10):2168-77. PubMed ID: 17885562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.